Skip to main content
Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
70.10
+0.60 (0.86%)
Nov 13, 2026, 1:30 PM CST

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
109,033240,25094,36523,5407,528-
Market Cap Growth
-43.30%154.60%300.87%212.69%--
Enterprise Value
105,437233,73884,68522,6946,297-
Last Close Price
70.10155.0061.5019.136.11-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-64.85----
PS Ratio
6823.976316.212123.71604.64587.23-
PB Ratio
12.4325.539.736.296.47-
P/TBV Ratio
12.4325.539.736.296.47-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-6145.021905.86582.91491.18-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.0300.000.010.030.06
Net Debt / Equity Ratio
-0.41-0.52-1.00-0.99-0.93-0.87
Net Debt / EBITDA Ratio
3.287.0913.887.483.582.60
Net Debt / FCF Ratio
8.6710.9818.148.534.214.44
Asset Turnover
0.000.000.010.020.010.03
Inventory Turnover
0.874.017.045.992.252.41
Quick Ratio
15.44106.97183.4250.4823.0415.00
Current Ratio
15.95109.71184.0250.8123.4115.26
Return on Equity (ROE)
-6.74%-3.68%-8.76%-19.92%-31.64%-64.89%
Return on Assets (ROA)
-7.49%-4.59%-6.59%-12.68%-20.53%-30.68%
Return on Capital Employed (ROCE)
-12.50%-7.50%-7.40%-13.70%-27.00%-34.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-0.57%-0.15%-0.62%-2.08%-3.80%-
FCF Yield
-0.38%-0.18%-0.56%-1.84%-3.41%-
Buyback Yield / Dilution
0.13%-7.94%-15.40%-5.77%-27.35%-23.49%